EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

From conventional screening to self-driving discovery: Organ-on-Chip platforms as engines for AI-guided nanomedicine

Kimia Asadi Jozani, Karen Shen, Nicky Anvari, Daniel Hocevar, Rosanna Jiang, Boyang Zhang, Ilya Yakavets, Yimu Zhao

Advanced Drug Delivery Reviews · 2026-05 · 232 · 115835

DOI: 10.1016/j.addr.2026.115835 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2026-05. Verfasst von Kimia Asadi Jozani und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Engineering, McMaster University, 1280 Main Street West, Hamilton, ON, L8S 4L8, Canada. Hauptthemen laut MEDLINE: Nanomedicine, Artificial Intelligence, Lab-On-A-Chip Devices, Nanoparticles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, National Sanitarium Association, Canada First Research Excellence Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nanoparticles have become an essential platform for next-generation drug delivery and therapeutic development, yet clinical translation remains limited by an incomplete understanding of their interactions within human biological systems. Organ-on-a-chip technology offers a powerful approach to evaluate efficacy and safety of nanomedicine under physiologically relevant conditions in human cells by recreating fluid flow, mechanical stress, barrier function, immune interactions and inter-organ communications. These advanced in vitro systems allow quantitative assessments of nanoparticle transport, distribution, and safety with improved human relevance compared to conventional cell culture and animal models. The integration of sensors within organ-on-a-chip platforms enables real-time monitoring of tissue responses and nanoparticle kinetics. Advances in automation and robotic liquid handling support scalable and reproducible testing across multiple tissue models. Artificial intelligence and active learning tools facilitate automated data analysis and experimental optimization, paving the way towards self-driving nanomedicine evaluation platforms that accelerate discovery and clinical translation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanomedicineArtificial IntelligenceLab-On-A-Chip DevicesNanoparticlesHumansAnimalsMicrophysiological SystemsDrug Delivery SystemsIntelligent Systems

Stichwörter der Autor:innen

Artificial intelligenceMachine learningNanomedicineOrgan-on-a-chipScreeningStem cells

Autor:innen und Institutionen

  • School of Biomedical Engineering, McMaster University, 1280 Main Street West, Hamilton, ON, L8S 4L8, Canada.
  • Toronto General Hospital Research Institute, University Health Network, Toronto, ON, M5G 2C4, Canada; Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, M5S 3E5, Canada.
  • Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, ON, M5S 3E5, Canada; Department of Computer Science, University of Toronto, Toronto, ON, M5S 2E4, Canada; Vector Institute, Toron…
  • Acceleration Consortium, University of Toronto, 160 College St, Toronto, ON, M5S 3E1, Canada.
  • School of Biomedical Engineering, McMaster University, 1280 Main Street West, Hamilton, ON, L8S 4L8, Canada; Department of Chemical Engineering, McMaster University, 1280 Main Street West, Hamilton, ON, L8S 4L8, Canada.
  • Acceleration Consortium, University of Toronto, 160 College St, Toronto, ON, M5S 3E1, Canada. Electronic address: i.yakavets@utoronto.ca.

Förderung

  • Canadian Institutes of Health Research
  • National Sanitarium Association
  • Canada First Research Excellence Fund

Zitieren

APA

Jozani, K. A., Shen, K., Anvari, N., Hocevar, D., Jiang, R., Zhang, B., Yakavets, I., & Zhao, Y. (2026). From conventional screening to self-driving discovery: Organ-on-Chip platforms as engines for AI-guided nanomedicine. Advanced Drug Delivery Reviews, 232, 115835. https://doi.org/10.1016/j.addr.2026.115835

Vancouver

Jozani KA, Shen K, Anvari N, Hocevar D, Jiang R, Zhang B, et al. From conventional screening to self-driving discovery: Organ-on-Chip platforms as engines for AI-guided nanomedicine. Advanced Drug Delivery Reviews. 2026;232:115835. doi:10.1016/j.addr.2026.115835

BibTeX
@article{Jozani2026,
  author = {Jozani, Kimia Asadi and Shen, Karen and Anvari, Nicky and Hocevar, Daniel and Jiang, Rosanna and Zhang, Boyang and Yakavets, Ilya and Zhao, Yimu},
  title = {From conventional screening to self-driving discovery: Organ-on-Chip platforms as engines for AI-guided nanomedicine},
  journal = {Advanced Drug Delivery Reviews},
  year = {2026},
  volume = {232},
  pages = {115835},
  doi = {10.1016/j.addr.2026.115835}
}
Kostenlos starten →